Back in August 2025, our family lost my brother-in-law Matt Aley to dedifferentiated liposarcoma (DDLS). Matt was so loved and he is so missed. He fought so hard and will always be remembered as our Superman, loving father and husband, and friend to so many. DDLS is a rare and extremely aggressive variant of sarcoma, and it is extremely hard to treat, especially in its advanced stage. Join my family and me with Team Matt Aley to honor Matt by never stopping the fight to end this disease once and for all.

Thanks to the Race to Cure Sarcoma events, SFA has invested over $20 million in sarcoma research, funding over 200 grants in 12 countries leading to close to 200 total publications, adding to the sarcoma research discourse. This has led to $26 million+ in additional funding, 10+ clinical trials with 5 additional pending, and 2 patents. Your investment in the RTCS events, is an investment in saving lives.